BioSpace News Archive

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases, today announced it will hold a webcast and conference call on Tuesday, June 25, 2019 at 8:00 a.m.

Terns Pharmaceuticals, Inc. today announced an exclusive licensing and collaboration agreement with GENFIT (GNFT), a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver-related diseases.

The data reported a 99% technical success rate for 20 gage FNB needles even though a “significant number of lesions were sampled from an angulated endoscope position, including pancreatic head masses.”

The award recognizes exceptional nursing knowledge and expert skills, consistently applied with compassion and integrity.

Surgical Theater is very excited to announce the Medical Device Division of the Israeli Ministry of Health approved marketing of the Surgical Navigation Advanced Platform (SNAP) and SuRgical Planner (SRP) systems.

Midatech Pharma US, Inc., an oncology supportive care specialty pharmaceutical company dedicated to helping patients manage cancer symptoms and treatment-related side effects, announced today that it has formally changed its name to Fortovia Therapeutics, Inc. (Fortovia or the “Company”).

Oxford Immunotec Global PLC (Nasdaq:OXFD) (the “Company”), a global, high-growth diagnostics company, today announced that it has appointed Patrick J. Balthrop, Sr. as Chairman of its board of directors.

To meet stringent regulatory requirements, such as the United States Pharmacopeia (USP), National Formulary (NF) or FDA, as well as production and budgetary demands, pharmaceutical manufacturers require high-volume precision blending of formulations on equipment that provides exceptional batch-to-batch consistency and repeatable results.

The American Association of Colleges of Osteopathic Medicine (AACOM) has launched the Choose DO Explorer, the Association’s first online search tool created for prospective students and health professions advisors.

The aggregate gross proceeds to Akero from the offering were approximately $105.8 million, before deducting underwriting discounts and commissions and other offering expenses.